Latest filing published 22 Jun 2018 for Audentes Therapeutics, Inc., €8,889.
Filing timeline
BuySaleInsider track record
David Nagler: trading record in brief
David Nagler appears in our data through filings on Audentes Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 15 September 2017 to 20 June 2018, the count stands at 8 filings.
No open-market purchase appears, only 4 sales worth €370k. The rest of the record consists of 4 option exercises. Since January 2018: no purchases and 2 sales on the market.
The newest entry dates from 22 June 2018: an open-market sale of €12k, in Audentes Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Nagler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,700 shares@ US$2.192.3% of flowCommon StockSEC:0001209191-18-039316:0
- 4,700 shares@ US$45.2546.7% of flowCommon StockSEC:0001209191-18-039316:1
- 300 shares@ US$2.190.1% of flowCommon StockSEC:0001209191-18-039316:2
- 300 shares@ US$46.023.0% of flowCommon StockSEC:0001209191-18-039316:3
- 3,750 shares@ US$2.191.8% of flowCommon StockSEC:0001209191-17-054440:0
- 3,750 shares@ US$30.0024.3% of flowCommon StockSEC:0001209191-17-054440:1
- 3,750 shares@ US$2.191.8% of flowCommon StockSEC:0001209191-17-053350:0
- 3,750 shares@ US$25.0020.0% of flowCommon StockSEC:0001209191-17-053350:1
8 of 8 declarations